📰 Genentech News
Page 224 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
December 15, 2022
The FDA has approved Tecentriq (atezolizumab) for patients aged ≥2 years with unresectable or metastatic alveolar soft part sarcoma.
December 15, 2022
/PRNewswire/ -- Historically, respiratory illnesses peak during the winter season. While experts predicted higher rates of respiratory viruses like COVID-19...
December 15, 2022
/PRNewswire/ -- Historically, respiratory illnesses peak during the winter season. While experts predicted higher rates of respiratory viruses like COVID-19...
December 15, 2022
VACAVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- The Vacaville City Council honored Jim DeKloe Professor and Director of the Solano Community College...
December 14, 2022
This study reports 20-year breast cancer incidence among participants in Women’s Health Initiative (WHI) trials randomized to conjugated equine estrogen (CEE) a
December 14, 2022
Investegate announcements from Oxford BioDynamics, Exercise period extension - existing share options
December 14, 2022
These variants could be used to screen patients and ensure that those with a higher risk of PML aren’t given drugs linked to the disease.
December 14, 2022
/PRNewswire/ -- DelveInsights Clostridium difficile Infection Market Insights report includes a comprehensive understanding of current treatment practices,...
December 14, 2022
The Clostridium difficile infection market is anticipated to surge owing to the launch of emerging therapies. The potential emerging treatment expected to launch in the forecast period includes
December 13, 2022
This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on the standards for reporting outcomes